BANDRONE Injection (Ibandronic Acid)

• Breast cancer bone metastases

• Postmenopausal osteoporosis

• Tumor-induced hypercalcemia

• The drug is administered intravenously – 1 vial (6 mg) in 100 mL of saline solution, with infusion lasting at least 15 minutes.
  Dosing frequency depends on the patient’s condition (typically every 3–4 weeks). Use strictly as prescribed by a physician.

Contraindications:

• Hypocalcemia

• Severe renal impairment

• Pregnancy

Side Effects:

• Flu-like symptoms

• Hypocalcemia

• Jaw osteonecrosis